Scheduled works on two Perth city centre bridges have been pushed back by a year each. The works form part of the final phase of the £150 million Cross Tay Link Road project. A Perth City Centre ...

Turns out new Marvel movie Thunderbolts isn’t actually titled that at all. But as the MCU roars in Phase 6, the change adds one more mystery into the timeline. Don’t just listen to our review ...

Port expansion aims to ease pressure on Bangkok Port and strengthen Thailand’s export capacity. PATTAYA, Thailand – Deputy Transport Minister Monporn Jareonsri has announced the acceleration ...

In a decisive move to solidify its smart city agenda and bolster public safety, the Lagos State Government has launched a round-the-clock digitised traffic enforcement system. A statement by the ...

Novartis has committed another $1.7 billion to its ambition to become a kidney disease leader. The Swiss drugmaker is making the outlay, around half of which is upfront, to buy Regulus ...

Semaglutide, a glucagon-like peptide-1 receptor agonist, is a candidate for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). In this ongoing phase 3, multicenter ...

The NHL will look different in Utah next season. Smith Entertainment Group announced Wednesday it has begun the first phase of renovations of Delta Center in Salt Lake City, pushing technology ...

SAN DIEGO, April 30, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the initiation of a Phase 3 registrational program to evaluate the efficacy, safety and ...

Popular snack brands including Lay’s and Tostitos will no longer contain artificial colors by the end of 2025, as PepsiCo aligns with a new federal initiative to eliminate petroleum-based synthetic ...

Rinvoq (upadacitinib) becomes the first oral JAK inhibitor approved by the FDA for the treatment of giant cell arteritis in adults, following robust data from the Phase III SELECT-GCA trial ...

Treasury Secretary Scott Bessent said Tuesday the Trump administration will take into account China's lack of compliance with a trade deal from the president's first term when it finalizes a new ...

AstraZeneca has come up short in another phase 3 trial of the AKT inhibitor Truqap, raising more questions about the blockbuster potential of the first-in-class cancer treatment. Alongside its ...